CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT06762964 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Fontan Circulation
Single Ventricle Heart Disease
HFpEF - Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Dapagliflozin tablet
DRUG: Placebo Tablet

Sponsor

Mayo Clinic